Provision of Deal Intelligence: Systematically monitor and analyze global and China licensing and M&A transactions, including deal terms, structures, valuations, and strategic rationales; maintain trackers and create concise summaries and benchmarks.
Provision of Competitive Intelligence: Profile key companies and assets; compare pipelines, clinical progress, and partnering activity; identify whitespace and differentiation opportunities.
Provision of Therapeutic Area Insights: Develop market landscape briefs for priority TAs (oncology, CVRM, R&I, V&I, rare disease), highlighting clinical and commercial dynamics relevant to BD.
Provision of China R&D Highlights: Track China-originated assets, pivotal trial readouts, NMPA regulatory updates, and emerging platforms; assess potential global relevance and partnering opportunities.
Provision of Commercial Landscape: Analyze market siz...